ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 118 filers reported holding ALLAKOS INC in Q1 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,870,000 | -59.0% | 25,000 | -50.0% | 0.06% | -61.7% |
| Q4 2020 | $7,000,000 | +14.6% | 50,000 | -33.3% | 0.17% | -28.9% |
| Q3 2020 | $6,109,000 | -57.0% | 75,000 | -62.0% | 0.24% | -56.6% |
| Q2 2020 | $14,193,000 | +59.5% | 197,515 | -1.2% | 0.54% | +31.2% |
| Q1 2020 | $8,898,000 | -68.9% | 200,000 | -33.3% | 0.41% | -63.8% |
| Q4 2019 | $28,608,000 | -18.1% | 300,000 | -32.4% | 1.14% | -46.3% |
| Q3 2019 | $34,920,000 | +24.0% | 444,100 | -31.7% | 2.13% | +31.4% |
| Q2 2019 | $28,165,000 | -7.3% | 650,000 | -13.3% | 1.62% | -21.2% |
| Q1 2019 | $30,375,000 | +287.4% | 750,000 | +400.0% | 2.05% | +222.3% |
| Q4 2018 | $7,841,000 | – | 150,000 | – | 0.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 270,965 | $12,055,000 | 6.94% |
| NEA Management Company, LLC | 2,268,188 | $100,912,000 | 5.27% |
| Fairmount Funds Management LLC | 178,662 | $7,949,000 | 4.82% |
| Redmile Group, LLC | 2,976,928 | $132,444,000 | 3.71% |
| Boxer Capital, LLC | 675,000 | $30,031,000 | 2.05% |
| Rock Springs Capital Management LP | 235,000 | $10,455,000 | 0.43% |
| Cormorant Asset Management, LP | 200,000 | $8,898,000 | 0.41% |
| RAMIUS ADVISORS LLC | 31,155 | $1,386,000 | 0.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 15,700 | $692,000 | 0.32% |
| Handelsinvest Investeringsforvaltning | 20,000 | $890,000 | 0.24% |